Erste Group Bank Forecasts Lower Earnings for Sandoz Group

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) – Analysts at Erste Group Bank reduced their FY2027 EPS estimates for shares of Sandoz Group in a research report issued to clients and investors on Wednesday, October 21st. Erste Group Bank analyst H. Engel now forecasts that the company will post earnings of $4.55 per share for the year, down from their previous forecast of $4.56. Erste Group Bank currently has a “Strong-Buy” rating on the stock. The consensus estimate for Sandoz Group’s current full-year earnings is $4.15 per share.

Sandoz Group Price Performance

Shares of OTCMKTS SDZNY opened at $99.68 on Tuesday. Sandoz Group has a 52 week low of $62.26 and a 52 week high of $100.34. The company’s 50-day moving average price is $87.13 and its 200 day moving average price is $83.64.

Sandoz Group Company Profile

Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. Its portfolio includes prescription medicines across therapeutic areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular treatments. The company also supplies complex generics, including injectable, inhaled and other specialty formulations.

Sandoz serves patients and healthcare providers through a broad international commercial and manufacturing network, with operations and products spanning Europe, North America, Asia and other global markets.